Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis
- PMID: 19332460
- DOI: 10.1161/CIRCULATIONAHA.108.848218
Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis
Abstract
Background: Cardiopulmonary bypass and cardiac surgery are associated with a significant systemic inflammatory response that may increase postoperative complications. This meta-analysis assessed whether the benefits and risks of corticosteroid use were dose dependent in adult cardiac surgery.
Methods and results: Randomized controlled trials of the use of corticosteroid prophylaxis in adult cardiac surgery (>18 years of age) requiring cardiopulmonary bypass were selected from MEDLINE (1966 to August 1, 2008), EMBASE (1988 to August 1, 2008), and the Cochrane controlled trials register without any language restrictions. A total of 3323 patients from 50 randomized controlled trials were identified and subject to meta-analysis. Corticosteroid prophylaxis reduced the risk of atrial fibrillation (25.1% versus 35.1%; number needed to treat, 10; relative risk, 0.74; 95% confidence interval [CI], 0.63 to 0.86; P<0.01) and length of stay in the intensive care unit (weighted mean difference, -0.37 days; 95% CI, -0.21 to -0.52; P<0.01) and hospital (weighted mean difference, -0.66 days; 95% CI, -0.77 to -1.25; P=0.03) compared with placebo. The use of corticosteroid was not associated with an increased risk of all-cause infection (relative risk, 0.93; 95% CI, 0.61 to 1.41; P=0.73), but hyperglycemia requiring insulin infusion after corticosteroid prophylaxis was common (28.2%; relative risk, 1.49; 95% CI, 1.11 to 2.01; P<0.01). No additional benefits were found on all outcomes beyond a total dose of 1000 mg hydrocortisone, and very high doses of corticosteroid were associated with prolonged mechanical ventilation.
Conclusions: Evidence suggests that low-dose corticosteroid is as effective as high-dose corticosteroid in reducing the risk of atrial fibrillation and duration of mechanical ventilation but with fewer potential side effects in adult cardiac surgery.
Comment in
-
Letter by Baker et al regarding article, "benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis".Circulation. 2009 Nov 17;120(20):e163. doi: 10.1161/CIRCULATIONAHA.109.872242. Circulation. 2009. PMID: 19917892 No abstract available.
Similar articles
-
The efficacy of glucocorticoids for the prevention of atrial fibrillation, or length of intensive care unite or hospital stay after cardiac surgery: a meta-analysis.Cardiovasc Ther. 2014 Jun;32(3):89-96. doi: 10.1111/1755-5922.12062. Cardiovasc Ther. 2014. PMID: 24495440 Review.
-
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis.J Thorac Cardiovasc Surg. 2010 Aug;140(2):364-72. doi: 10.1016/j.jtcvs.2010.02.042. Epub 2010 Apr 9. J Thorac Cardiovasc Surg. 2010. PMID: 20381820 Review.
-
Letter by Baker et al regarding article, "benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis".Circulation. 2009 Nov 17;120(20):e163. doi: 10.1161/CIRCULATIONAHA.109.872242. Circulation. 2009. PMID: 19917892 No abstract available.
-
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation.Pharmacotherapy. 2007 Mar;27(3):360-8. doi: 10.1592/phco.27.3.360. Pharmacotherapy. 2007. PMID: 17316148
-
Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials.J Thorac Cardiovasc Surg. 2005 May;129(5):997-1005. doi: 10.1016/j.jtcvs.2004.07.042. J Thorac Cardiovasc Surg. 2005. PMID: 15867772
Cited by
-
Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review.J Thorac Dis. 2024 Feb 29;16(2):1503-1520. doi: 10.21037/jtd-23-1626. Epub 2024 Feb 23. J Thorac Dis. 2024. PMID: 38505057 Free PMC article. Review.
-
Impact of CytoSorb® on interleukin-6 in cardiac surgery.Front Cardiovasc Med. 2023 Aug 30;10:1166093. doi: 10.3389/fcvm.2023.1166093. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37711559 Free PMC article.
-
Risk of Atrial Fibrillation in Pemphigus Vulgaris.Indian J Dermatol. 2022 Nov-Dec;67(6):639-644. doi: 10.4103/ijd.IJD_69_17. Indian J Dermatol. 2022. PMID: 36998858 Free PMC article.
-
Postoperative atrial fibrillation: from mechanisms to treatment.Eur Heart J. 2023 Mar 21;44(12):1020-1039. doi: 10.1093/eurheartj/ehad019. Eur Heart J. 2023. PMID: 36721960 Free PMC article. Review.
-
Characteristics of immune clusters and cell abundance in patients with different subtypes of nonparoxysmal atrial fibrillation.Sci Rep. 2023 Jan 18;13(1):968. doi: 10.1038/s41598-022-26749-z. Sci Rep. 2023. PMID: 36653368 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical